165 related articles for article (PubMed ID: 36828177)
1. Impact of Cryopreservation on Extracorporeal Photopheresis (ECP)-Treated Leukocyte Subsets.
Trunk AD; Radwanski K; Heber C; Taylor A; Hsieh F; Harris A; Lee CJ; Phillips JD; Couriel DR
Transplant Cell Ther; 2023 Jun; 29(6):396.e1-396.e5. PubMed ID: 36828177
[TBL] [Abstract][Full Text] [Related]
2. Cryopreserved ECP-treated lymphocytes maintain apoptotic response and anti-proliferative effect.
Radwanski K; Heber C; Min K
J Clin Apher; 2015 Jun; 30(3):154-61. PubMed ID: 25213780
[TBL] [Abstract][Full Text] [Related]
3. An alternative for extracorporeal photopheresis: 8-methoxypsoralen and UVA-treated leucocytes from allogeneic donors improve graft-versus-host disease in mice.
Budde H; Papert S; Reichardt HM; Jarry H; Riggert J; Legler TJ
Vox Sang; 2018 Nov; 113(8):803-810. PubMed ID: 30353554
[TBL] [Abstract][Full Text] [Related]
4. Extracorporeal photophoresis: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(6):1-82. PubMed ID: 23074497
[TBL] [Abstract][Full Text] [Related]
5. Favorable impact of extracorporeal photopheresis in acute and chronic graft versus host disease: Prospective single-center study.
Sakellari I; Gavriilaki E; Batsis I; Mallouri D; Panteliadou AK; Lazaridou A; Vardi A; Constantinou V; Yannaki E; Papalexandri A; Kaloyannidis P; Smias C; Anagnostopoulos A
J Clin Apher; 2018 Dec; 33(6):654-660. PubMed ID: 30394564
[TBL] [Abstract][Full Text] [Related]
6. Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients.
Weitz M; Strahm B; Meerpohl JJ; Bassler D
Cochrane Database Syst Rev; 2014 Feb; (2):CD009898. PubMed ID: 24569961
[TBL] [Abstract][Full Text] [Related]
7. Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients.
Weitz M; Strahm B; Meerpohl JJ; Schmidt M; Bassler D
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD009898. PubMed ID: 26666581
[TBL] [Abstract][Full Text] [Related]
8. Modulation of B Cells and Homing Marker on NK Cells Through Extracorporeal Photopheresis in Patients With Steroid-Refractory/Resistant Graft-Vs.-Host Disease Without Hampering Anti-viral/Anti-leukemic Effects.
Wang L; Ni M; Hückelhoven-Krauss A; Sellner L; Hoffmann JM; Neuber B; Luft T; Hegenbart U; Schönland S; Kleist C; Sill M; Chen BA; Wuchter P; Eckstein V; Krüger W; Hilgendorf I; Yerushalmi R; Nagler A; Müller-Tidow C; Ho AD; Dreger P; Schmitt M; Schmitt A
Front Immunol; 2018; 9():2207. PubMed ID: 30349527
[TBL] [Abstract][Full Text] [Related]
9. Steroid-sparing effect of extracorporeal photopheresis in the therapy of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Ussowicz M; Musiał J; Mielcarek M; Tomaszewska A; Nasiłowska-Adamska B; Kałwak K; Gorczyńska E; Mariańska B; Chybicka A
Transplant Proc; 2013 Nov; 45(9):3375-80. PubMed ID: 24182819
[TBL] [Abstract][Full Text] [Related]
10. Modified extracorporeal photopheresis with cells from a healthy donor for acute graft-versus-host disease in a mouse model.
Budde H; Kolb S; Salinas Tejedor L; Wulf G; Reichardt HM; Riggert J; Legler TJ
PLoS One; 2014; 9(8):e105896. PubMed ID: 25148404
[TBL] [Abstract][Full Text] [Related]
11. Shaping of CD56
Ni M; Wang L; Yang M; Neuber B; Sellner L; Hückelhoven-Krauss A; Schubert ML; Luft T; Hegenbart U; Schönland S; Wuchter P; Chen BA; Eckstein V; Krüger W; Yerushalmi R; Beider K; Nagler A; Müller-Tidow C; Dreger P; Schmitt M; Schmitt A
Front Immunol; 2019; 10():547. PubMed ID: 30949182
[TBL] [Abstract][Full Text] [Related]
12. Cryopreservation of mononuclear cells before extracorporeal photochemotherapy does not impair their anti-proliferative capabilities.
Merlin E; Hannani D; Veyrat-Masson R; Chassagne J; Gabert F; Berger M; Deméocq F; Plumas J; Kanold J
Cytotherapy; 2011 Feb; 13(2):248-55. PubMed ID: 20662606
[TBL] [Abstract][Full Text] [Related]
13. Extracorporeal photopheresis for the treatment of chronic graft versus host disease.
Kansu E; Ward D; Sanchez AP; Cunard R; Hayran M; Huseyin B; Vaughan M; Ku G; Curtin P; Mulroney C; Costello C; Castro JE; Wieduwilt M; Corringham S; Ihasz-Davis A; Nelson C; Ball ED
Hematology; 2022 Dec; 27(1):785-794. PubMed ID: 35802815
[TBL] [Abstract][Full Text] [Related]
14. Thymopoiesis, Alterations in Dendritic Cells and Tregs, and Reduced T Cell Activation in Successful Extracorporeal Photopheresis Treatment of GVHD.
Flinn AM; Ehrlich A; Roberts C; Wang XN; Chou J; Gennery AR
J Clin Immunol; 2021 Jul; 41(5):1016-1030. PubMed ID: 33651234
[TBL] [Abstract][Full Text] [Related]
15. Extracorporeal Photopheresis (ECP) and the Potential of Novel Biomarkers in Optimizing Management of Acute and Chronic Graft vs. Host Disease (GvHD).
Mankarious M; Matthews NC; Snowden JA; Alfred A
Front Immunol; 2020; 11():81. PubMed ID: 32082329
[TBL] [Abstract][Full Text] [Related]
16. Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers.
Bojanic I; Worel N; Pacini CP; Stary G; Piekarska A; Flinn AM; Schell KJ; Gennery AR; Knobler R; Lacerda JF; Greinix HT; Pulanic D; Crossland RE
Front Immunol; 2023; 14():1086006. PubMed ID: 36875063
[TBL] [Abstract][Full Text] [Related]
17. Retrospective Multicenter Study of Extracorporeal Photopheresis in Steroid-Refractory Acute and Chronic Graft-versus-Host Disease.
Oarbeascoa G; Lozano ML; Guerra LM; Amunarriz C; Saavedra CA; Garcia-Gala JM; Viejo A; Revilla N; Acosta Fleitas C; Arroyo JL; Martinez Revuelta E; Galego A; Hernandez-Maraver D; Kwon M; Diez-Martin JL; Pascual C;
Biol Blood Marrow Transplant; 2020 Apr; 26(4):651-658. PubMed ID: 31917270
[TBL] [Abstract][Full Text] [Related]
18. Extracorporeal photopheresis as a promising strategy for the treatment of graft-versus-host disease after CAR T-cell therapy.
Han H; Wang L; Ding Y; Neuber B; Hückelhoven-Krauss A; Lin M; Yao H; Chen Q; Sauer T; Schubert ML; Guo Z; Müller-Tidow C; Schmitt M; Schmitt A
Blood Adv; 2024 Jun; 8(11):2675-2690. PubMed ID: 38359409
[TBL] [Abstract][Full Text] [Related]
19. The concurrent administration of imatinib with extracorporeal photopheresis leads to complete and durable responses in patients with refractory sclerotic type chronic graft-versus-host disease.
Alsuliman T; Magro L; Coiteux V; Gauthier J; Srour M; Lionet A; Beauvais D; Yakoub-Agha I
Curr Res Transl Med; 2020 Apr; 68(2):71-76. PubMed ID: 31631014
[TBL] [Abstract][Full Text] [Related]
20. Extracorporeal photopheresis as second-line therapy for patients with acute graft-versus-host disease: does the number of cells treated matter?
Worel N; Lehner E; Führer H; Kalhs P; Rabitsch W; Mitterbauer M; Hopfinger G; Greinix HT
Transfusion; 2018 Apr; 58(4):1045-1053. PubMed ID: 29446444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
